Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ear, Middle | 7 | 2023 | 26 | 2.350 |
Why?
|
| Tympanoplasty | 6 | 2019 | 13 | 2.010 |
Why?
|
| Temporal Bone | 13 | 2025 | 61 | 1.790 |
Why?
|
| Tympanic Membrane | 9 | 2023 | 13 | 1.670 |
Why?
|
| Tympanic Membrane Perforation | 5 | 2019 | 7 | 1.670 |
Why?
|
| Ear Diseases | 4 | 2024 | 21 | 1.610 |
Why?
|
| Cholesteatoma | 2 | 2023 | 7 | 1.540 |
Why?
|
| Cranial Fossa, Middle | 4 | 2016 | 12 | 1.540 |
Why?
|
| Cochlear Implantation | 4 | 2017 | 34 | 1.510 |
Why?
|
| Otolaryngology | 3 | 2018 | 56 | 1.460 |
Why?
|
| Hearing Loss, Sensorineural | 7 | 2020 | 52 | 1.440 |
Why?
|
| Meningitis | 2 | 2025 | 23 | 1.370 |
Why?
|
| Facial Nerve | 5 | 2022 | 33 | 1.340 |
Why?
|
| Otologic Surgical Procedures | 3 | 2018 | 13 | 1.260 |
Why?
|
| Mastoid | 4 | 2018 | 16 | 1.240 |
Why?
|
| Cochlear Implants | 3 | 2019 | 37 | 1.220 |
Why?
|
| Hearing Loss, Conductive | 3 | 2020 | 15 | 1.200 |
Why?
|
| Otitis Externa | 3 | 2019 | 5 | 1.150 |
Why?
|
| Cholesteatoma, Middle Ear | 3 | 2023 | 8 | 1.140 |
Why?
|
| Earache | 2 | 2019 | 4 | 1.070 |
Why?
|
| Ear, Inner | 2 | 2025 | 37 | 1.020 |
Why?
|
| Ear Canal | 3 | 2024 | 17 | 0.990 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 2 | 2016 | 5 | 0.960 |
Why?
|
| Ethiopia | 6 | 2020 | 36 | 0.880 |
Why?
|
| Speech Perception | 2 | 2015 | 74 | 0.840 |
Why?
|
| Otitis Media | 1 | 2023 | 20 | 0.790 |
Why?
|
| Hearing Loss, Sudden | 3 | 2014 | 5 | 0.760 |
Why?
|
| Stapes Surgery | 2 | 2019 | 6 | 0.760 |
Why?
|
| Petrous Bone | 1 | 2022 | 10 | 0.750 |
Why?
|
| Adult | 31 | 2024 | 28578 | 0.720 |
Why?
|
| Cochlea | 2 | 2019 | 50 | 0.710 |
Why?
|
| Myringosclerosis | 2 | 2018 | 2 | 0.700 |
Why?
|
| Middle Aged | 32 | 2024 | 28206 | 0.690 |
Why?
|
| Humans | 60 | 2025 | 95799 | 0.690 |
Why?
|
| Tinnitus | 2 | 2014 | 24 | 0.670 |
Why?
|
| Meniere Disease | 1 | 2020 | 14 | 0.640 |
Why?
|
| Osteomyelitis | 2 | 2019 | 57 | 0.610 |
Why?
|
| Otosclerosis | 1 | 2019 | 4 | 0.610 |
Why?
|
| Osseointegration | 1 | 2019 | 10 | 0.610 |
Why?
|
| Otolaryngologists | 1 | 2019 | 5 | 0.600 |
Why?
|
| Postoperative Complications | 5 | 2019 | 2592 | 0.600 |
Why?
|
| Ciprofloxacin | 1 | 2019 | 25 | 0.600 |
Why?
|
| Electroconvulsive Therapy | 1 | 2019 | 26 | 0.590 |
Why?
|
| Multidetector Computed Tomography | 1 | 2019 | 61 | 0.590 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2018 | 8 | 0.570 |
Why?
|
| Job Satisfaction | 1 | 2019 | 86 | 0.570 |
Why?
|
| Ear Neoplasms | 1 | 2018 | 14 | 0.570 |
Why?
|
| Hearing Loss | 2 | 2017 | 65 | 0.560 |
Why?
|
| Hearing | 2 | 2018 | 64 | 0.560 |
Why?
|
| Ear Ossicles | 1 | 2018 | 8 | 0.560 |
Why?
|
| Male | 32 | 2024 | 45685 | 0.550 |
Why?
|
| Neuroma, Acoustic | 2 | 2015 | 21 | 0.550 |
Why?
|
| Competency-Based Education | 1 | 2018 | 38 | 0.540 |
Why?
|
| Encephalocele | 2 | 2016 | 25 | 0.530 |
Why?
|
| Reoperation | 2 | 2017 | 707 | 0.520 |
Why?
|
| Female | 30 | 2024 | 49869 | 0.510 |
Why?
|
| Prosthesis Failure | 1 | 2017 | 125 | 0.500 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2016 | 17 | 0.490 |
Why?
|
| Bone Diseases | 1 | 2016 | 53 | 0.480 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 316 | 0.470 |
Why?
|
| Deafness | 2 | 2015 | 48 | 0.470 |
Why?
|
| Round Window, Ear | 1 | 2015 | 3 | 0.470 |
Why?
|
| Myocutaneous Flap | 1 | 2015 | 5 | 0.470 |
Why?
|
| Retrospective Studies | 13 | 2023 | 10273 | 0.460 |
Why?
|
| Child | 12 | 2022 | 7618 | 0.460 |
Why?
|
| Soft Tissue Injuries | 1 | 2015 | 16 | 0.460 |
Why?
|
| Semicircular Canals | 1 | 2015 | 29 | 0.460 |
Why?
|
| Mobile Applications | 1 | 2016 | 79 | 0.450 |
Why?
|
| Clinical Competence | 2 | 2018 | 854 | 0.450 |
Why?
|
| Craniotomy | 1 | 2015 | 97 | 0.440 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2014 | 3 | 0.440 |
Why?
|
| Otomycosis | 1 | 2014 | 1 | 0.440 |
Why?
|
| Physical Examination | 1 | 2015 | 153 | 0.430 |
Why?
|
| Candidiasis | 1 | 2014 | 39 | 0.420 |
Why?
|
| Aspergillosis | 1 | 2014 | 39 | 0.420 |
Why?
|
| Electrodes, Implanted | 1 | 2015 | 219 | 0.420 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 197 | 0.410 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2016 | 189 | 0.410 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 647 | 0.400 |
Why?
|
| Surgical Flaps | 1 | 2015 | 259 | 0.390 |
Why?
|
| Adolescent | 11 | 2020 | 9873 | 0.390 |
Why?
|
| Young Adult | 8 | 2018 | 7026 | 0.370 |
Why?
|
| Audiometry, Pure-Tone | 4 | 2018 | 29 | 0.360 |
Why?
|
| Biomedical Research | 1 | 2016 | 441 | 0.350 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 1192 | 0.350 |
Why?
|
| Aged | 18 | 2024 | 20848 | 0.330 |
Why?
|
| Internship and Residency | 2 | 2018 | 1134 | 0.320 |
Why?
|
| Surveys and Questionnaires | 3 | 2020 | 2859 | 0.320 |
Why?
|
| India | 2 | 2020 | 138 | 0.300 |
Why?
|
| HIV Infections | 1 | 2018 | 974 | 0.280 |
Why?
|
| Treatment Outcome | 10 | 2019 | 9167 | 0.280 |
Why?
|
| Vestibular Nerve | 1 | 2008 | 33 | 0.280 |
Why?
|
| Vestibular Diseases | 1 | 2008 | 29 | 0.280 |
Why?
|
| Cadaver | 2 | 2021 | 204 | 0.280 |
Why?
|
| Child, Preschool | 5 | 2018 | 3970 | 0.270 |
Why?
|
| Developing Countries | 2 | 2018 | 91 | 0.260 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2006 | 15 | 0.250 |
Why?
|
| Headache | 1 | 2006 | 82 | 0.240 |
Why?
|
| Stapes | 1 | 2025 | 6 | 0.230 |
Why?
|
| Mastoidectomy | 1 | 2024 | 3 | 0.220 |
Why?
|
| Osteonecrosis | 1 | 2024 | 21 | 0.220 |
Why?
|
| Endoscopy | 4 | 2023 | 374 | 0.210 |
Why?
|
| Recurrence | 2 | 2025 | 1211 | 0.210 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2004 | 10 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2016 | 2773 | 0.200 |
Why?
|
| Skull Neoplasms | 2 | 2008 | 27 | 0.190 |
Why?
|
| Mastoiditis | 2 | 2017 | 4 | 0.180 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 3904 | 0.180 |
Why?
|
| Infant | 3 | 2018 | 3360 | 0.170 |
Why?
|
| Radiography | 4 | 2008 | 823 | 0.150 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 1 | 2019 | 7 | 0.150 |
Why?
|
| Myringoplasty | 1 | 2019 | 1 | 0.150 |
Why?
|
| Head and Neck Neoplasms | 3 | 1995 | 1087 | 0.150 |
Why?
|
| Parotid Gland | 1 | 2019 | 26 | 0.150 |
Why?
|
| Fascia | 1 | 2019 | 32 | 0.150 |
Why?
|
| Pediatricians | 1 | 2019 | 24 | 0.150 |
Why?
|
| Tonsillectomy | 1 | 2019 | 31 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2015 | 3639 | 0.150 |
Why?
|
| Cartilage | 1 | 2019 | 116 | 0.150 |
Why?
|
| Oncologists | 1 | 2019 | 38 | 0.150 |
Why?
|
| Skull Base | 1 | 2019 | 52 | 0.150 |
Why?
|
| Necrosis | 1 | 2019 | 210 | 0.140 |
Why?
|
| Hospitals, Special | 1 | 2018 | 8 | 0.140 |
Why?
|
| Hospital Departments | 1 | 2018 | 14 | 0.140 |
Why?
|
| Hospitals, Public | 1 | 2018 | 15 | 0.140 |
Why?
|
| Bone Conduction | 1 | 2018 | 5 | 0.140 |
Why?
|
| Granulation Tissue | 1 | 2018 | 15 | 0.140 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2018 | 74 | 0.140 |
Why?
|
| Otitis | 1 | 2017 | 2 | 0.130 |
Why?
|
| Medical Staff, Hospital | 1 | 2018 | 110 | 0.130 |
Why?
|
| Otoscopy | 1 | 2016 | 1 | 0.130 |
Why?
|
| Transplantation, Autologous | 1 | 2018 | 361 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 7215 | 0.120 |
Why?
|
| Computers, Handheld | 1 | 2016 | 33 | 0.120 |
Why?
|
| Prevalence | 1 | 2020 | 1349 | 0.120 |
Why?
|
| Smartphone | 1 | 2016 | 54 | 0.120 |
Why?
|
| Carcinoma, Medullary | 1 | 1995 | 9 | 0.120 |
Why?
|
| Mediastinal Emphysema | 1 | 1995 | 6 | 0.120 |
Why?
|
| Goals | 1 | 2016 | 68 | 0.120 |
Why?
|
| Biopsy | 3 | 2013 | 1208 | 0.120 |
Why?
|
| Temporal Arteries | 1 | 2015 | 8 | 0.120 |
Why?
|
| Nasal Sprays | 1 | 2015 | 9 | 0.120 |
Why?
|
| Incidental Findings | 1 | 2016 | 99 | 0.120 |
Why?
|
| Ear, External | 1 | 2015 | 24 | 0.120 |
Why?
|
| Diatrizoate | 1 | 1995 | 11 | 0.120 |
Why?
|
| Plasma Substitutes | 1 | 1995 | 10 | 0.110 |
Why?
|
| Telemetry | 1 | 2015 | 36 | 0.110 |
Why?
|
| User-Computer Interface | 1 | 2016 | 196 | 0.110 |
Why?
|
| Dextrans | 1 | 1995 | 78 | 0.110 |
Why?
|
| Branchioma | 1 | 1995 | 1 | 0.110 |
Why?
|
| Tongue Diseases | 1 | 1994 | 9 | 0.110 |
Why?
|
| Mouthwashes | 1 | 1994 | 5 | 0.110 |
Why?
|
| Cerebellopontine Angle | 1 | 1994 | 10 | 0.110 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 1994 | 13 | 0.110 |
Why?
|
| Simulation Training | 1 | 2016 | 108 | 0.110 |
Why?
|
| Premedication | 1 | 1994 | 58 | 0.110 |
Why?
|
| Anti-Infective Agents, Local | 1 | 1994 | 25 | 0.110 |
Why?
|
| Indium Radioisotopes | 1 | 1994 | 10 | 0.110 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 60 | 0.110 |
Why?
|
| Clavicle | 1 | 1994 | 13 | 0.110 |
Why?
|
| Cerebellar Neoplasms | 1 | 1994 | 45 | 0.110 |
Why?
|
| Patient Positioning | 1 | 2015 | 65 | 0.110 |
Why?
|
| Fractures, Spontaneous | 1 | 1994 | 17 | 0.110 |
Why?
|
| Arteries | 1 | 2015 | 181 | 0.110 |
Why?
|
| Biopsy, Needle | 2 | 1994 | 231 | 0.110 |
Why?
|
| Abscess | 1 | 1994 | 94 | 0.110 |
Why?
|
| Mandibular Neoplasms | 1 | 1994 | 22 | 0.110 |
Why?
|
| Parotitis | 1 | 1994 | 6 | 0.110 |
Why?
|
| Prosthesis Design | 1 | 2015 | 310 | 0.110 |
Why?
|
| Operative Time | 1 | 2015 | 167 | 0.110 |
Why?
|
| Debridement | 1 | 2014 | 60 | 0.110 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1994 | 33 | 0.110 |
Why?
|
| Monitoring, Intraoperative | 1 | 2015 | 116 | 0.100 |
Why?
|
| Radius Fractures | 1 | 1994 | 34 | 0.100 |
Why?
|
| Humeral Fractures | 1 | 1994 | 25 | 0.100 |
Why?
|
| Lightning Injuries | 1 | 1993 | 2 | 0.100 |
Why?
|
| Tomography, X-Ray | 1 | 2013 | 18 | 0.100 |
Why?
|
| Bronchoscopy | 1 | 1995 | 175 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2014 | 126 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2016 | 936 | 0.100 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 1993 | 8 | 0.100 |
Why?
|
| Sweating, Gustatory | 1 | 1993 | 1 | 0.100 |
Why?
|
| Sweat Glands | 1 | 1993 | 6 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 847 | 0.100 |
Why?
|
| Mycosis Fungoides | 1 | 1993 | 30 | 0.100 |
Why?
|
| Leukocytes | 1 | 1994 | 213 | 0.100 |
Why?
|
| Wound Healing | 1 | 2015 | 378 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2015 | 369 | 0.100 |
Why?
|
| Nasal Septum | 1 | 1993 | 27 | 0.100 |
Why?
|
| Cytomegalovirus Infections | 1 | 1994 | 155 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2882 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2016 | 815 | 0.090 |
Why?
|
| Logistic Models | 1 | 2016 | 1267 | 0.090 |
Why?
|
| Adenoma | 1 | 1995 | 260 | 0.090 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 132 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 1994 | 237 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1957 | 0.090 |
Why?
|
| Anticoagulants | 1 | 1995 | 463 | 0.090 |
Why?
|
| Graft Survival | 1 | 2015 | 942 | 0.090 |
Why?
|
| Curriculum | 1 | 2016 | 615 | 0.090 |
Why?
|
| Aging | 1 | 2016 | 766 | 0.090 |
Why?
|
| Thyroid Neoplasms | 1 | 1995 | 443 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1994 | 1087 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 1993 | 345 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1981 | 0.080 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1994 | 366 | 0.080 |
Why?
|
| Contrast Media | 1 | 1995 | 1096 | 0.080 |
Why?
|
| Graft Rejection | 1 | 2015 | 1126 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2015 | 2480 | 0.070 |
Why?
|
| Spiral Ganglion | 2 | 2001 | 25 | 0.070 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2008 | 11 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 1994 | 557 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2015 | 3106 | 0.070 |
Why?
|
| Time Factors | 1 | 2017 | 5561 | 0.070 |
Why?
|
| Skin Neoplasms | 1 | 1993 | 621 | 0.070 |
Why?
|
| Photography | 1 | 2007 | 38 | 0.070 |
Why?
|
| United States | 1 | 2020 | 7764 | 0.060 |
Why?
|
| Decision Trees | 1 | 2007 | 63 | 0.060 |
Why?
|
| Cranial Sinuses | 1 | 2006 | 16 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1993 | 1463 | 0.060 |
Why?
|
| Risk | 1 | 2007 | 665 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2007 | 348 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2006 | 243 | 0.050 |
Why?
|
| Skull Fractures | 1 | 2004 | 28 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2007 | 983 | 0.050 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2003 | 2 | 0.050 |
Why?
|
| Otitis Media, Suppurative | 1 | 2003 | 4 | 0.050 |
Why?
|
| Tuberculosis, Miliary | 1 | 2003 | 4 | 0.050 |
Why?
|
| Risk Factors | 1 | 2013 | 5961 | 0.050 |
Why?
|
| Tobramycin | 1 | 2001 | 5 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2007 | 682 | 0.040 |
Why?
|
| Gentamicins | 1 | 2001 | 21 | 0.040 |
Why?
|
| Hair Cells, Auditory | 1 | 2001 | 26 | 0.040 |
Why?
|
| Seizures | 1 | 2004 | 331 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2003 | 208 | 0.040 |
Why?
|
| Hearing Tests | 1 | 2019 | 11 | 0.040 |
Why?
|
| Transplants | 1 | 2019 | 43 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2001 | 787 | 0.030 |
Why?
|
| Geniculate Ganglion | 1 | 1996 | 2 | 0.030 |
Why?
|
| Hearing Disorders | 1 | 1996 | 8 | 0.030 |
Why?
|
| Subcutaneous Emphysema | 1 | 1995 | 8 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 2386 | 0.030 |
Why?
|
| Anthropometry | 1 | 1996 | 78 | 0.030 |
Why?
|
| Dissection | 1 | 1996 | 45 | 0.030 |
Why?
|
| Labyrinthitis | 1 | 1995 | 2 | 0.030 |
Why?
|
| Audiometry | 1 | 1995 | 14 | 0.030 |
Why?
|
| Ossification, Heterotopic | 1 | 1995 | 32 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1995 | 75 | 0.030 |
Why?
|
| Choristoma | 1 | 1995 | 63 | 0.030 |
Why?
|
| Iodine | 1 | 1994 | 44 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1994 | 10 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1995 | 420 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 1994 | 61 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 1995 | 161 | 0.030 |
Why?
|
| Gadolinium | 1 | 1994 | 106 | 0.030 |
Why?
|
| Carotid Sinus | 1 | 1994 | 20 | 0.030 |
Why?
|
| Cytodiagnosis | 1 | 1994 | 47 | 0.030 |
Why?
|
| Syncope | 1 | 1994 | 37 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 1994 | 206 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1994 | 303 | 0.030 |
Why?
|
| Sezary Syndrome | 1 | 1993 | 12 | 0.020 |
Why?
|
| Hypopharyngeal Neoplasms | 1 | 1993 | 15 | 0.020 |
Why?
|
| Silicone Elastomers | 1 | 1993 | 8 | 0.020 |
Why?
|
| Siloxanes | 1 | 1993 | 5 | 0.020 |
Why?
|
| Hyperplasia | 1 | 1993 | 149 | 0.020 |
Why?
|
| Rupture | 1 | 1993 | 62 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 1993 | 91 | 0.020 |
Why?
|
| Laryngeal Neoplasms | 1 | 1993 | 89 | 0.020 |
Why?
|
| Mouth Neoplasms | 1 | 1994 | 202 | 0.020 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 1994 | 149 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 1994 | 1008 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 1993 | 193 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 1994 | 1613 | 0.020 |
Why?
|
| Skin | 1 | 1993 | 604 | 0.020 |
Why?
|
| Age Factors | 1 | 1993 | 1957 | 0.020 |
Why?
|
| Prognosis | 1 | 1994 | 3990 | 0.020 |
Why?
|
| Developed Countries | 1 | 2003 | 25 | 0.010 |
Why?
|
| Antitubercular Agents | 1 | 2003 | 61 | 0.010 |
Why?
|
| Rare Diseases | 1 | 2003 | 71 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2001 | 245 | 0.010 |
Why?
|
| Cell Death | 1 | 2001 | 264 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 857 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 1739 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1965 | 0.010 |
Why?
|
| Cell Count | 1 | 1995 | 202 | 0.010 |
Why?
|
| Cell Survival | 1 | 1995 | 1029 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1994 | 506 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2001 | 2605 | 0.010 |
Why?
|